Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report

Fig. 2

Clinical course of the patient. The patient’s creatinine levels showed rapid improvement 3 days after the discontinuation of lansoprazole, a drug for which the DLST was positive. Lansoprazole had been used safely for more than 4 years before the initiation of nivolumab therapy. DLST: drug-induced lymphocyte stimulation test; NSCLC: non-small cell lung cancer

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us